{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:40:26Z","timestamp":1740145226246,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["20ck0106537h0002"],"award-info":[{"award-number":["20ck0106537h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-023-00991-7","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T19:02:38Z","timestamp":1698778958000},"page":"337-344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Establishment and characterization of NCC-LMS3-C1: a novel patient-derived cell line of leiomyosarcoma"],"prefix":"10.1007","volume":"37","author":[{"given":"Yuki","family":"Yoshimatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Osaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yooksil","family":"Sin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuto","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Tanzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6405-7792","authenticated-orcid":false,"given":"Tadashi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"991_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/805614","volume":"2012","author":"B Edris","year":"2012","unstructured":"Edris B, Fletcher JA, West RB, van de Rijn M, Beck AH. Comparative gene expression profiling of benign and malignant lesions reveals candidate therapeutic compounds for leiomyosarcoma. Sarcoma. 2012;2012: 805614.","journal-title":"Sarcoma"},{"key":"991_CR2","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/pbc.23252","volume":"57","author":"A Ferrari","year":"2011","unstructured":"Ferrari A, Sultan I, Huang TT, et al. Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database. Pediatr Blood Cancer. 2011;57:943\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"991_CR3","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/1097-0142(19920701)70:1<114::AID-CNCR2820700119>3.0.CO;2-U","volume":"70","author":"P Gustafson","year":"1992","unstructured":"Gustafson P, Will\u00e9n H, Baldetorp B, Fern\u00f6 M, Akerman M, Rydholm A. Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content. Cancer. 1992;70:114\u20139.","journal-title":"Cancer"},{"key":"991_CR4","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1002\/ijc.22239","volume":"119","author":"JR Toro","year":"2006","unstructured":"Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CD, Devesa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978\u20132001: an analysis of 26,758 cases. Int J Cancer. 2006;119:2922\u201330.","journal-title":"Int J Cancer"},{"key":"991_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1440-1827.1997.tb04514.x","volume":"47","author":"T Ishida","year":"1997","unstructured":"Ishida T, Kuwada Y, Motoi N, Oka T, Machinami R. Dedifferentiated chondrosarcoma of the rib with a malignant mesenchymomatous component: an autopsy case report. Pathol Int. 1997;47:397\u2013403.","journal-title":"Pathol Int"},{"key":"991_CR6","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1245\/s10434-013-2876-y","volume":"20","author":"RA Gladdy","year":"2013","unstructured":"Gladdy RA, Qin LX, Moraco N, Agaram NP, Brennan MF, Singer S. Predictors of survival and recurrence in primary leiomyosarcoma. Ann Surg Oncol. 2013;20:1851\u20137.","journal-title":"Ann Surg Oncol"},{"key":"991_CR7","volume-title":"Enzinger and Weiss's soft tissue tumors","author":"Weiss","year":"2013","unstructured":"Weiss. Enzinger and Weiss\u2019s soft tissue tumors. St. Louis: Mosby Inc.; 2013."},{"key":"991_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11864-021-00928-y","volume":"23","author":"B Kasper","year":"2022","unstructured":"Kasper B, D\u2019Ambrosio L, Davis EJ, et al. What clinical trials are needed for treatment of leiomyosarcoma? Curr Treat Options Oncol. 2022;23:439\u201349.","journal-title":"Curr Treat Options Oncol"},{"key":"991_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12957-022-02584-4","volume":"20","author":"S Kannan","year":"2022","unstructured":"Kannan S, Chong HH, Chew B, et al. Leiomyosarcoma in the extremities and trunk wall: systematic review and meta-analysis of the oncological outcomes. World J Surg Oncol. 2022;20:124.","journal-title":"World J Surg Oncol"},{"key":"991_CR10","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1158\/1535-7163.MCT-15-0074","volume":"14","author":"BA Teicher","year":"2015","unstructured":"Teicher BA, Polley E, Kunkel M, et al. Sarcoma cell line screen of oncology drugs and investigational agents identifies patterns associated with gene and microRNA expression. Mol Cancer Ther. 2015;14:2452\u201362.","journal-title":"Mol Cancer Ther"},{"key":"991_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7171\/jbt.18-2902-002","volume":"29","author":"A Bairoch","year":"2018","unstructured":"Bairoch A. The Cellosaurus, a cell-Line knowledge resource. J Biomol Tech. 2018;29:25\u201338.","journal-title":"J Biomol Tech"},{"key":"991_CR12","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1093\/bioinformatics\/bti677","volume":"21","author":"H Willenbrock","year":"2005","unstructured":"Willenbrock H, Fridlyand J. A comparison study: applying segmentation to array CGH data for downstream analyses. Bioinformatics. 2005;21:4084\u201391.","journal-title":"Bioinformatics"},{"key":"991_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/biostatistics\/kxh008","volume":"5","author":"AB Olshen","year":"2004","unstructured":"Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics. 2004;5:557\u201372.","journal-title":"Biostatistics"},{"key":"991_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/bioinformatics\/btl646","volume":"23","author":"ES Venkatraman","year":"2007","unstructured":"Venkatraman ES, Olshen AB. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics. 2007;23:657\u201363.","journal-title":"Bioinformatics"},{"key":"991_CR15","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC, et al. COSMIC: the catalogue of somatic mutations in cancer. Nucl Acids Res. 2019;47:D941\u20137.","journal-title":"Nucl Acids Res"},{"key":"991_CR16","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/jjco\/hyx096","volume":"47","author":"M Sakumoto","year":"2017","unstructured":"Sakumoto M, Takahashi M, Oyama R, et al. Establishment and proteomic characterization of NCC-LMS1-C1, a novel cell line of primary leiomyosarcoma of the bone. Jpn J Clin Oncol. 2017;47:954\u201361.","journal-title":"Jpn J Clin Oncol"},{"key":"991_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s13577-020-00443-6","volume":"34","author":"R Noguchi","year":"2021","unstructured":"Noguchi R, Yoshimatsu Y, Ono T, et al. Establishment and characterization of NCC-LMS2-C1-a novel patient-derived cancer cell line of leiomyosarcoma. Hum Cell. 2021;34:279\u201388.","journal-title":"Hum Cell"},{"key":"991_CR18","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/ijms18071414","volume":"18","author":"T Eckschlager","year":"2017","unstructured":"Eckschlager T, Plch J, Stiborova M, Hrabeta J. Histone deacetylase inhibitors as anticancer drugs. Int J Mol Sci. 2017;18:1414.","journal-title":"Int J Mol Sci"},{"key":"991_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4137\/CMO.S7194","volume":"6","author":"J Lee","year":"2012","unstructured":"Lee J, McGuire C. Clinical efficacy of vorinostat in a patient with leiomyosarcoma. Clin Med Insights Oncol. 2012;6:101\u20135.","journal-title":"Clin Med Insights Oncol"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-023-00991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-023-00991-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-023-00991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T01:13:38Z","timestamp":1704330818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-023-00991-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["991"],"URL":"https:\/\/doi.org\/10.1007\/s13577-023-00991-7","relation":{},"ISSN":["1749-0774"],"issn-type":[{"type":"electronic","value":"1749-0774"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"23 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ethics committee of the National Cancer Center approved the use of clinical materials for this study (approval number 2004\u2013050).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent for publication was provided by the patient.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}